Synopsis:
Obesity is a major comorbidity in psoriatic disease. It increases inflammation, worsens disease severity, reduces treatment response, and raises cardiovascular risks and mortality. This GRAPPA workshop aims to equip rheumatologists and healthcare providers with evidence-based, multidisciplinary education on the link between psoriasis and obesity, along with updates on new therapeutic options.
Workshop learning objectives:
By the end of the workshop, participants will be able to:
- Describe the epidemiology, pathology, and impact of obesity on psoriasis (PsO) and psoriatic arthritis (PsA).
- Explain the mechanistic links between adipose tissue, inflammation, and disease activity.
- Assess clinical evidence for different strategies to treat obesity related to psoriatic disease.
- Implement patient-centered approaches for weight management in clinical care.
| Agenda - Thursday 29 October | ||||
|---|---|---|---|---|
|
|
Workshop chairpersons: Mitsumasa Kishimoto and Katy Leung
|
|||
|
1045-1245 |
Welcome and introduction Mitsumasa Kishimoto GRAPPA updates Katy Leung Treatment selection in PsD Arthur Kavanaugh Q&A What exactly is axial psoriatic arthritis? Peter Nash Prevention of structural damage in PsA Lai-Shan Tam Q&A Radiograph quiz Ashish Mathew |
|||
|
1245-1330 |
BREAK |
|||
|
1330-1600 |
Chairpersons: Mitsumasa Kishimoto and Kichul Shin
MRI Workshop – Lecture and Quiz (part 1: SI) Ashish Mathew MRI Workshop – Lecture (part 2: Spine) Ashish Mathew BREAK D2T and C2M PsA update Satoshi Kawaai (YGRAPPA) QUIZ (clinical cases) Satoshi Kawaai (YGRAPPA) Wrap up Katy Leung |
|||
